TQ0239 |
PF-06291874
|
1393124-08-7
|
99.14%
|
|
PF-06291874 (Glucagon receptor antagonists-4) (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor.
|
T6876 |
Liraglutide
|
204656-20-2
|
99.04%
|
|
Liraglutide (Liraglutida) is a long-acting GLP-1 receptor agonist.
|
T28182 |
NNC 92-1687
|
22903-37-3
|
98.93%
|
|
NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
|
TP1376 |
GLP-1(7-37) acetate(106612-94-6 free base)
|
1450806-98-0
|
98.89%
|
|
Glp-1(7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
|
T0294 |
6α-Methylprednisolone 21-hemisuccinate sodium salt
|
2375-03-3
|
98.69%
|
|
6α-Methylprednisolone 21-hemisuccinate sodium salt (Asmacortone), a water-soluble ester, is used for allergic, cardiac, and hypoxic emergencies.
|
T8748 |
Exendin-4 acetate
|
914454-01-6
|
98.65%
|
|
Exendin-4 acetate is a 39 amino acid peptide.Exendin-4 acetate is a long-acting GLP-1 receptor agonist(IC50 = 3.22 nM).
|
T19850L |
Semaglutide Acetate
|
1997361-85-9
|
98.42%
|
|
Semaglutide Acetate is an agonist of a glucagon-like peptide 1 (GLP-1) receptor and can be used in studies about the treatment of type 2 diabetes.
|
T76279 |
Retatrutide
|
2381089-83-2
|
98.31%
|
|
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor...
|
T77781 |
Lotiglipron
|
2401892-75-7
|
98.3%
|
|
Lotiglipron (PF-07081532) is an orally active and potent GLP-1R agonist that reduces blood glucose and body weight and may be useful in the study of type 2 diabe...
|
TP1103 |
Cotadutide acetate
|
TP1103
|
98.28%
|
|
Cotadutide acetate (MEDI0382 acetate) is a potent peptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptor with EC50 of 6.9 pM and 10.2 pM, ...
|
TP2071L |
Bay 55-9837 acetate
|
|
98.27%
|
|
Bay 55-9837 acetate is a potent and highly selective VPAC2 agonist(Kd = 0.65 nM) and can be used in type 2 diabetes studies.
|
TQ0124 |
BETP
|
1371569-69-5
|
97.92%
|
|
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).
|
T7364 |
NNC-0640
|
307986-98-7
|
97.55%
|
|
NNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
|
TP1382L |
HAEGTFTSDVS acetate
|
TP1382L
|
97.47%
|
|
HAEGTFTSDVS acetate is the first N-terminal 1-11 residues of GLP-1 which stimulates insulin secretion from pancreatic β-cells.
|
T3422 |
GRA Ex-25
|
307983-31-9
|
97.39%
|
|
GRA Ex-25 (GRA-Ex-25) is an inhibitor of glucagon receptor.
|
TP1111L |
Tirzepatide Acetate(2023788-19-2 free base)
|
TP1111L
|
97.3%
|
|
Tirzepatide acetate is a dual GIP / GLP-1 receptor agonist.
|
T15389L |
Glucagon (1-29), bovine, human, porcine hydrochloride
|
28270-04-4
|
95.65%
|
|
Glucagon (1-29), bovine, human, porcine hydrochloride is a peptide hormone, produced by pancreatic α-cells. It activates HNF4α and increases HNF4α phosphorylatio...
|
T12431 |
PF-06882961
|
2230198-02-2
|
95.1%
|
|
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
|
T22893 |
L-168049
|
191034-25-0
|
100%
|
|
L-168049 is a selective and non-competitive antagonist of human glucagon receptor with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine, respectiv...
|
T60047L |
V-0219 hydrochloride
|
T60047L
|
100%
|
|
V-0219 hydrochloride, an orally-active positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), is utilized in obesity-associated di...
|